论文部分内容阅读
Background and Study Aims: The aim of this study was to assess the safety and usefulness of capsule endoscopy (CE) in pediatric patients with a suspicion of C rohn’s disease. Patients and Methods: CE was used in 12 patients (four girls, e ight boys; age 12-16; weight range 43-87kg). The indication was a clinical sus picion of Crohn’s disease not confirmed with traditional methods. Gastroscopy, colonoscopy, and small-bowel follow-through examinations were carried out in a ll of the patients, without any diagnostic findings. Ileoscopy was possible in 5 0%of the patients, and the ileal mucosa and biopsies were normal in all cases. Results: The capsule was easily swallowed by all of the patients. They all excre ted the capsule normally, and no complications were observed in any case. CE ide nti-fied lesions suggestive of Crohn’s disease in seven of the 12 (58.3%), an d the majority of the lesions were in the ileum. Conclusions: CE is safe in pediatric patients over 12 years of age. The procedure appears to be a very useful diagnostic tool in children with Crohn’s disease.
Background and Study Aims: The aim of this study was to assess the safety and usefulness of capsule endoscopy (CE) in pediatric patients with a suspicion of C rohn’s disease. Patients and Methods: CE was used in 12 patients (four girls, e ight boys; age 12-16; weight range 43-87 kg). The indication was a clinical sus picion of Crohn’s disease not confirmed with traditional methods. Gastroscopy, colonoscopy, and small-bowel follow-through examinations were carried out in a ll of the Patients, without any diagnostic findings. Ileoscopy was possible in 5 0% of the patients, and the ileal mucosa and biopsies were normal in all cases. Results: The capsule was easily swallowed by all of the patients. They all swollen by all of the patients. They all excre ted the capsule , and no complications were observed in any case. CE ide nti-fied lesions suggestive of Crohn’s disease in seven of the 12 (58.3%), an d the majority of the lesions were in the ileum. Conclusions: CE is safe in pediatric patients over 12 years of age. The pro cedure appears to be a very useful diagnostic tool in children with Crohn’s disease.